Sonoma Pharmaceuticals Inc. (NASDAQ:SNOA) rose 16.40% after hours of trading following a 7.89% decline during the regular session. The company's Burn Relief Hydrogel, which targets minor burns and skin irritations, is its first large-scale consumer burn relief offering. Distribution runs through an unnamed U.S.-based partner that supplies CVS and Walmart. This follows Sonoma's established presence in professional healthcare wound and burn care protocols. The stock closed at $2.10 after the normal session, but has fallen 27.08% over the past 12 months.